Focan, C <br/><br/>
Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.  [electronic resource] 

 -  Anticancer research   
 - 4665-72 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0250-7005 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--administration & dosage<br/>Adult<br/>Aged<br/>Antimetabolites, Antineoplastic--administration & dosage<br/>Chemotherapy, Adjuvant<br/>Chi-Square Distribution<br/>Colonic Neoplasms--drug therapy<br/>Colorectal Neoplasms--drug therapy<br/>Disease-Free Survival<br/>Dose-Response Relationship, Drug<br/>Female<br/>Fluorouracil--administration & dosage<br/>Follow-Up Studies<br/>Humans<br/>Infusions, Intravenous<br/>Injections, Intravenous<br/>Leucovorin--administration & dosage<br/>Levamisole--administration & dosage<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Portal System<br/>Radiotherapy, Adjuvant<br/>Rectal Neoplasms--drug therapy<br/>Survival Rate